-+ 0.00%
-+ 0.00%
-+ 0.00%

Bushang Pharmaceutical (603858.SH): Atomoxetine hydrochloride oral solution obtained drug registration certificate

Zhitongcaijing·10/09/2026 09:09:05
Listen to the news

Zhitong Finance App News, Buchang Pharmaceutical (603858.SH) issued an announcement. The company recently received the “Drug Registration Certificate” for the oral solution of atomoxetine hydrochloride approved and issued by the State Drug Administration. This medication is used to treat attention-deficit/hyperactivity disorder (ADHD) in children and adolescents aged 6 and over.